News
Hosted on MSN5mon
Examining two cases of immune thrombotic thrombocytopenic purpura associated with COVID-19 vaccine CoronaVacMore information: Zhangbiao Long et al, Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac, Frontiers of Medicine (2024). DOI: 10.1007 ...
Purpose. A case of a patient who developed thrombotic thrombocytopenic purpura (TTP) after consuming a weight-loss product containing green tea is reported. Summary. A 38-year-old, 68-kg Caucasian ...
Takeda has reported positive results from a phase 3 trial of its experimental therapy TAK-755 for ultra-rare disease congenital thrombotic thrombocytopenic purpura (cTTP), setting up regulatory ...
A recombinant replacement for the ADAMTS13 protein (Adzynma) missing in congenital thrombotic thrombocytopenic purpura (TTP) restored levels and reduced acute TTP events, according to interim ...
Hemophilia, Thrombotic Thrombocytopenic Purpura (TTP), and the use of Direct Oral Anticoagulants (DOACs) will be discussed. Review when DOACs are used in patient treatment Discuss the critical role of ...
This case scored a 3 on the Naranjo et al. [26] scale of causality, classifying as "possible" the likelihood that green tea caused the patient's TTP. It is unknown why no other reports have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results